Patents by Inventor Prabhu Dutt Mishra
Prabhu Dutt Mishra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10501492Abstract: Purified compounds of formula I are described. Compounds include all stereoisomeric forms and all tautomeric forms of the compounds of formula I and pharmaceutically acceptable salts and derivatives. Processes for the production of the antibacterial compounds by fermentation of the microorganism belonging to Streptomyces species (PM0626271/MTCC 5447) and to pharmaceutical compositions containing one or more of the novel compounds as active ingredient and their use in medicines for treatment and prevention of diseases caused by bacterial infections are described.Type: GrantFiled: August 31, 2010Date of Patent: December 10, 2019Assignees: National Centre for Polar and Ocean Research (NCPOR), Foundation for Neglected Disease Research (FNDR)Inventors: Prabhu Dutt Mishra, Girish Badrinath Mahajan
-
Publication number: 20160354430Abstract: This invention relates to a method of treatment of cancer comprising administering compound of Formula (1) or derivatives or pharmaceutically acceptable salts thereof.Type: ApplicationFiled: August 18, 2016Publication date: December 8, 2016Applicant: PIRAMAL ENTERPRISES LIMITEDInventors: Prabhu Dutt Mishra, Sreekumar Sankaranarayanan Eyyammadichiyl, Saji David GEORGE, Shailendra SONAWANE, Narayan Subhash CHAKOR, Abhijit ROYCHOWDHURY, Rajiv SHARMA
-
Patent number: 9475842Abstract: This invention relates to an isolated compound of Formula (1) or derivatives or pharmaceutically acceptable salts thereof. The invention also includes all isomeric and tautomeric forms of the compound of Formula (1) or the derivatives thereof. The present invention further relates to processes for the production of the compound of Formula (1) by fermentation of the fungal strain of Actinomycetes (PM0895172/MTCC 684), pharmaceutical compositions comprising the compound of Formula (1) as the active ingredient; and use of the compounds or composition containing them in the treatment of cancer.Type: GrantFiled: May 6, 2013Date of Patent: October 25, 2016Assignee: Piramal Enterprises LimitedInventors: Prabhu Dutt Mishra, Sreekumar Sankaranarayanan Eyyammadichiyl, Saji David George, Shailendra Sonawane, Narayan Subhash Chakor, Abhijit Roychowdhury, Rajiv Sharma
-
Publication number: 20150080312Abstract: This invention relates to an isolated, compound of Formula (1) or derivatives or pharmaceutically acceptable salts thereof. The invention also includes all isomeric and tautomeric forms of the compound of Formula (1) or the derivatives thereof. The present invention further relates to processes for the production of the compound of Formula (1) by fermentation of the fungal strain of Actinomycetes (PM0895172/MTCC 684), pharmaceutical compositions comprising the compound of Formula (1) as the active ingredient; and use of the compounds or composition containing them in the treatment of cancer.Type: ApplicationFiled: May 6, 2013Publication date: March 19, 2015Applicant: PIRAMAL ENTERPRISES LIMITEDInventors: Prabhu Dutt Mishra, Sreekumar Sankaranarayanan Eyyammadichiyl, Saji David George, Shailendra Sonawane, Narayan Subhash Chakor, Abhijit Roychowdhury, Rajiv Sharma
-
Publication number: 20140348919Abstract: This invention relates to novel purified compounds of Formula I. The invention includes all stereoisomeric forms and all tautomeric forms of the compounds of Formula I and pharmaceutically acceptable salts and derivatives. The present invention further relates to processes for the production of the novel antibacterial compounds by fermentation of the microorganism belonging to Streptomyces species (PM0626271/MTCC 5447) and to pharmaceutical compositions containing one or more of the novel compounds as active ingredient and their use in medicines for treatment and prevention of diseases caused by bacterial infections.Type: ApplicationFiled: August 8, 2014Publication date: November 27, 2014Applicant: PIRAMAL ENTERPRISES LIMITEDInventors: PRABHU DUTT MISHRA, GIRISH BADRINATH MAHAJAN
-
Patent number: 8637683Abstract: The present invention provides compounds represented by formula (1): wherein, R1, R2, R3 and R4 are as defined in the specification, in all their stereoisomeric and tautomeric forms and mixtures thereof in all ratios, and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable polymorphs and prodrugs. The invention also relates to processes for the manufacture of compounds of formula (1) and pharmaceutical compositions containing them. The compounds and the pharmaceutical compositions of the present invention are useful for the treatment of cancer. The present invention further provides a method of treatment of cancer by administering a therapeutically effective amount of the said compound of formula (1) or its pharmaceutical composition, to a mammal in need thereof.Type: GrantFiled: November 15, 2010Date of Patent: January 28, 2014Assignees: Piramal Enterprises Limited, Oncotest GmbHInventors: Prabhu Dutt Mishra, Shafee Mohammed Abdul, Ram Vishwakarma, Heinz-Herbert Fiebig, Gerhard Kelter
-
Publication number: 20130130992Abstract: This invention relates to purified compound of formula (1). The invention includes all isomeric forms and all tautomeric forms of the compound of formula (1) and pharmaceutically acceptable salts thereof. The present invention further relates to processes for the production of the compound of formula (1) by fermentation of the fungal strain of sterile mycelium (PM0509732/MTCC5544) and to pharmaceutical compositions containing the compound as active ingredient and its use in medicines for treatment of cancer.Type: ApplicationFiled: August 5, 2011Publication date: May 23, 2013Applicants: ONCOTEST GMBH, PIRAMAL ENTERPRISES LIMITEDInventors: Sunil Kumar Jaiwant Rao Deshmukh, Shilpa Amit Verekar, Prabhu Dutt Mishra, Sreekumar Sankaranarayanan Eyyammadichiyil, Kalpana Sanjay Joshi, Heinz-Herbert Fiebig, Gerhard Kelter
-
Publication number: 20120245183Abstract: The present invention provides compounds represented by formula (1): wherein, R1, R2, R3 and R4 are as defined in the specification, in all their stereoisomeric and tautomeric forms and mixtures thereof in all ratios, and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable polymorphs and prodrugs. The invention also relates to processes for the manufacture of compounds of formula (1) and pharmaceutical compositions containing them. The compounds and the pharmaceutical compositions of the present invention are useful for the treatment of cancer. The present invention further provides a method of treatment of cancer by administering a therapeutically effective amount of the said compound of formula (1) or its pharmaceutical composition, to a mammal in need thereof.Type: ApplicationFiled: November 15, 2010Publication date: September 27, 2012Applicants: ONCOTEST GMBH, PIRAMAL LIFE SCIENCES LIMITEDInventors: Prabhu Dutt Mishra, Shafee Mohammed Abdul, Ram Vishwakarma, Heinz-Herbert Fiebig, Gerhard Kelter
-
Publication number: 20120156295Abstract: Purified compounds of formula I are described. Compounds include all stereoisomeric forms and all tautomeric forms of the compounds of formula I and pharmaceutically acceptable salts and derivatives. Processes for the production of the antibacterial compounds by fermentation of the microorganism belonging to Streptomyces species (PM0626271/MTCC 5447) and to pharmaceutical compositions containing one or more of the novel compounds as active ingredient and their use in medicines for treatment and prevention of diseases caused by bacterial infections are described.Type: ApplicationFiled: August 31, 2010Publication date: June 21, 2012Inventors: Prabhu Dutt Mishra, Girish Badrinath Mahajan
-
Publication number: 20110177180Abstract: The present invention relates to a herbal composition comprising extract of the plant Indigofera heterantha. The invention also relates to a process for the preparation of the herbal composition. The invention further relates to the use of the herbal composition for the treatment of viral infection, particularly caused by herpes simplex viruses.Type: ApplicationFiled: September 23, 2009Publication date: July 21, 2011Applicant: PIRAMAL LIFE SCIENCES LIMITEDInventors: Becky Mary Thomas, Saravanabalaji Shanmugam, Arvind Saklani, Shreekant Nagesh Godbole, Vinayak Raghoba Naik, Prabhu Dutt Mishra, Sivaramakrishnan Hariharan, Arno Appavoo Enose, Ritu Kaushik